Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIAN Nasal Spray Phase 1 SAD Study
NCT05194358Phase 1Completed
- Sponsor
- Emergent BioSolutions
- Start
- Dec 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of amyl nitrite in cyanide poisoning (7 cohorts), sponsored by Emergent BioSolutions. Primary endpoints: Related Serious Adverse Events at Day 8 and Methemoglobin Level at 360 minutes. Started Dec 2021; status: completed.
02
Drugs
amyl nitrite
03
Conditions
cyanide poisoning
Beyond the preview
Go deeper on NCT05194358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05194358.